Last reviewed · How we verify

NCT05210556

Oral Antibiotic Bowel Preparation in Gynecologic Oncology Surgery

Completed Last updated 28 March 2025
What this trial tests

trial testing Diagnosed with Surgical Site Infection in Surgical Site Infection in 778 participants. Completed in 30 June 2024.

Timeline
22 December 2021
Primary endpoint
1 February 2022
30 June 2024

Quick facts

Lead sponsorWellSpan Health
StatusCompleted
Study typeOBSERVATIONAL
Enrollment778
Start date22 December 2021
Primary completion1 February 2022
Estimated completion30 June 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

WellSpan Health — full company profile →

Who can join

Adults 18 to 99, female only, with Surgical Site Infection or Surgical Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate whether the use of a preoperative antibiotic bowel regimen is associated with a reduced risk of deep organ/space surgical site infection in gynecologic oncology surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Surgical Site Infection

Currently open trials in the same condition.

Other WellSpan Health trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05210556.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing